These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5571173)

  • 21. [The apparent duration of the development of cancer of the prostate before and after estrogens].
    Cibert J; Garbit JL; Massoumi R; Ogawa A
    J Urol Nephrol (Paris); 1968 Mar; 74(3):177-8. PubMed ID: 5646971
    [No Abstract]   [Full Text] [Related]  

  • 22. [The future of patients with prostatic cancer. Results in 1971 in 76 cases histologically diagnosed during 1960-1966].
    Reziciner S; Reinhardt W; Rieffel R; Westphal L; Bollack C
    Acta Urol Belg; 1972 Jan; 40(1):117-25. PubMed ID: 5040191
    [No Abstract]   [Full Text] [Related]  

  • 23. ["Androgenic shock" during treatment of prostate gland cancer].
    Religa Z
    Pol Przegl Chir; 1969; 41(4):Suppl 4a:534+. PubMed ID: 4896406
    [No Abstract]   [Full Text] [Related]  

  • 24. [The distant future of patients with prostatic cancer treated mainly with hormones. Conclusion of the colloquium].
    Mombaerts J
    Acta Urol Belg; 1972 Jan; 40(1):155-6. PubMed ID: 5040198
    [No Abstract]   [Full Text] [Related]  

  • 25. Oestrogen therapy in prostatic cancer.
    Smith PH; Akdas A
    Scand J Urol Nephrol Suppl; 1980; 55():91-4. PubMed ID: 6938043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The distant future of patients with prostatic cancer treated mainly by hormones].
    Wincqz PJ
    Acta Urol Belg; 1972 Jan; 40(1):143-4. PubMed ID: 5040195
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects of estrongens in treatment of cancer of the prostate. Pyknotic index and cytology of the prostate].
    Kurth KH; Skoluda D; Schmidt H
    J Urol Nephrol (Paris); 1974 Dec; 80(12 pt 2):453-7. PubMed ID: 4469319
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prolactin and cancer of the prostate (III). Changes in plasma prolactin and testosterone after hormone treatment in prostatic cancer].
    Maganto Pavón E; Mateos Torres JA; Mayayo Dehesa T; Allona Almagro A; Boronat Tormo F; Escudero Barrilero A
    Arch Esp Urol; 1982; 35(4):222-33. PubMed ID: 7138091
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prophylactic roentgen therapy of the breast in men treated with estrogenic hormones for prostatic cancer].
    Hatteland K; Ostrem T
    Tidsskr Nor Laegeforen; 1965 Sep; 85(18):1400-2. PubMed ID: 5882530
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of the functional state of the liver on the course of prostatic cancer and the effectiveness of estrogen therapy].
    Pytel' AIa
    Urol Nefrol (Mosk); 1973; 38(5):47-9. PubMed ID: 4782767
    [No Abstract]   [Full Text] [Related]  

  • 31. [Andromastectomy for the prevention of gynecomastia in the treatment of prostatic cancer].
    Olbrisch RR; Sintermann W; Mauermayer W
    Fortschr Med; 1978 Feb; 96(8):372-3. PubMed ID: 631718
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prognosis for prostatic cancer treated with hormones].
    Sauvage R; Stubbe P
    Acta Urol Belg; 1972 Jan; 40(1):145-9. PubMed ID: 5040196
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experiences with hormonal treatment of prostatic carcinoma].
    Enfedjieff M
    Z Urol Nephrol; 1974 Mar; 67(3):171-3. PubMed ID: 4848715
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hormone therapy of cancer of the prostate].
    Albeaux-Fernet M
    Recenti Prog Med; 1969 May; 46(5):479-85. PubMed ID: 5409228
    [No Abstract]   [Full Text] [Related]  

  • 35. [The distant future of patients with prostatic cancer treated mainly with hormones].
    Denis R
    Acta Urol Belg; 1972 Jan; 40(1):133-6. PubMed ID: 5040193
    [No Abstract]   [Full Text] [Related]  

  • 36. [Remarks on hormonal treatment of prostatic canecer].
    Verrière P; Burlet P
    J Med Lyon; 1967 May; 48(121):869-70. PubMed ID: 5616975
    [No Abstract]   [Full Text] [Related]  

  • 37. [Mastectomy prior to treatment with estrogens in carcinoma of the prostate].
    Pagliere H; Soldano E; Scorticati C
    Rev Argent Urol Nefrol; 1965; 34(1):552-5. PubMed ID: 5887918
    [No Abstract]   [Full Text] [Related]  

  • 38. [Survival time of prostatic cancer treated exclusively with hormones].
    Lafrance L
    Acta Urol Belg; 1972 Jan; 40(1):106-7. PubMed ID: 5040188
    [No Abstract]   [Full Text] [Related]  

  • 39. [Medical management in the presence of cancer of the prostate].
    Cereseto PL
    Rev Asoc Med Argent; 1965 Jul; 79(7):346-8. PubMed ID: 5853394
    [No Abstract]   [Full Text] [Related]  

  • 40. [Apropos of hormone-independent cancer of the prostate].
    Chauvin HF
    J Urol Nephrol (Paris); 1967 Mar; 73(3):334-6. PubMed ID: 6054950
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.